Allied Market Research

2024

India Biosimilars And Follow-on Biologics Market

India Biosimilars and Follow-On Biologics Market Size, Share, Competitive Landscape and Trend Analysis Report by Product (ERYTHROPOETIN, GRANULOCYTE-COLONY STIMULATING FACTOR, GROWTH HORMONE, ALFA INTERFERON, BETA INTERFERON, MONOCLONAL ANTIBODY, FOLLITROPIN, Others), by Application (BLOOD DISORDER, CANCER, CHRONIC AND AUTOIMMUNE DISEASE, GROWTH HORMONE DEFICIENCY, Others) and by Manufacturing (IN-HOUSE MANUFACTURING, CONTRACT MANUFACTURING ORGANIZATION): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

India Biosimilars and Follow-On Biologics Market Report Highlights

Aspects Details
India Biosimilars and Follow-On Biologics Market By Product
By Product
  • ERYTHROPOETIN
  • GRANULOCYTE-COLONY STIMULATING FACTOR
  • GROWTH HORMONE
  • ALFA INTERFERON
  • BETA INTERFERON
  • MONOCLONAL ANTIBODY
  • FOLLITROPIN
  • Others
India Biosimilars and Follow-On Biologics Market By Application
By Application
  • BLOOD DISORDER
  • CANCER
  • CHRONIC AND AUTOIMMUNE DISEASE
  • GROWTH HORMONE DEFICIENCY
  • Others
India Biosimilars and Follow-On Biologics Market By Manufacturing
By Manufacturing
  • IN-HOUSE MANUFACTURING
  • CONTRACT MANUFACTURING ORGANIZATION
Key Market Players
Key Market Players

Biocon Ltd., Dr. Reddy's Laboratories Ltd., Nicholas Piramal India Ltd., Cipla Ltd., Wockhardt Ltd., Reliance Life Sciences Pvt. Ltd., Hetero Drugs Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Cadila Healthcare Ltd.

Loading Table Of Content...

India Biosimilars And Follow-on Biologics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032